Peer-reviewed veterinary case report
Insulinoma in dogs: a review.
- Journal:
- Journal of the American Animal Hospital Association
- Year:
- 2012
- Authors:
- Goutal, Caroline M et al.
- Affiliation:
- Department of Veterinary Clinical Sciences · United States
- Species:
- dog
Plain-English summary
Insulinomas are rare tumors in dogs that develop in the pancreas and cause the body to produce too much insulin, which can lead to low blood sugar levels. This can result in various symptoms, including weakness, confusion, and even seizures. Diagnosing and treating insulinomas can be difficult, and the outcome can vary greatly depending on the treatment options chosen. This review looks at the latest information on how to diagnose, treat, and understand the prognosis for dogs with insulinomas.
Abstract
Insulinomas are rare malignant functional pancreatic tumors of the β cells that retain the ability to produce and secrete insulin. Insulinomas are the most common pancreatic neuroendocrine tumor in dogs that can induce a variety of clinical signs that result from hypoglycemia and secondary neuroglycopenic and adrenergic effects. Diagnosis and treatment is considered challenging, and the prognosis can be extremely variable depending on the therapeutic choices. This review aims to summarize and update classic knowledge with current trends in the diagnosis, treatment, and prognosis of insulinomas.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/22474047/